Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

Post by: Geert in Immunic Press Release
NEW YORK, Oct. 14, 2021…
read more
15 Oct 2021
0

Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board

Post by: Geert in Coave Press Release
Coave Therapeutics appoints Olivier Danos…
read more
12 Oct 2021
0

Immunic, Inc. Enrolls First Patient in Its Phase 2 CALLIPER Trial of IMU-838 in Progressive Multiple Sclerosis

Post by: Geert in Immunic Press Release
NEW YORK, Sept. 30, 2021…
read more
01 Oct 2021
0

Immunic and the University Medical Center Goettingen Sign License Agreement Covering the Combination of DHODH Inhibitors and Nucleoside Analogues to Treat Viral Infections, Including COVID-19

Post by: Geert in Immunic Press Release
Immunic and the University Medical…
read more
22 Sep 2021
0

Coave Therapeutics and Théa Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigmentosa

Post by: Geert in Horama Press Release
Coave Therapeutics and Théa Open…
read more
16 Sep 2021
0

ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19

Post by: Geert in Exevir Press Release
ExeVir Announces First Patient Enrolled…
read more
01 Sep 2021
0

Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Post by: Geert in Cardior Press Release
Cardior Raises €64 M Series…
read more
25 Aug 2021
0

ExeVir announces first subjects dosed in Phase I clinical study of potent COVID-19 neutralizing antibody

Post by: Geert in Exevir Press Release
ExeVir announces first subjects dosed…
read more
18 Aug 2021
0

Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform

Post by: Geert in Horama Press Release
Coave Therapeutics Closes €33 million…
read more
22 Jul 2021
0

Immunic, Inc. Announces Closing of $45.0 Million Public Offering

Post by: Geert in Immunic Press Release
Immunic, Inc. Announces Closing of…
read more
20 Jul 2021
0